PRDX6 promotes proliferation and induces chemo-resistance via peroxidase activity in Toledo diffuse large B-cell lymphoma cells

BACKGROUND: Diffuse large B cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphomas. Despite the application of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) regimen being effective on 70–80% of DLBCL patients, the remaining 20–30% develop an even more...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Zhigang, Liu, Tingrong, Liu, Xiangfu, Lu, Ying, Sun, Yanling, Xiao, Ruozhi, Fan, Ruifang, Liu, Lingling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798764/
https://www.ncbi.nlm.nih.gov/pubmed/35116928
http://dx.doi.org/10.21037/tcr.2019.08.36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798764/
https://www.ncbi.nlm.nih.gov/pubmed/35116928
http://dx.doi.org/10.21037/tcr.2019.08.36

Ejemplares similares